THOMPSON SIEGEL & WALMSLEY LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1008322 RICHMOND, VA

Back to XERS Full portfolio

Position in XERS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$509,414

+$8,758 QoQ

Shares Held

64,320

-25.5% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#107

of 238 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

THOMPSON SIEGEL & WALMSLEY LLC holds $144,286,637 across 7 Drug Manufacturers - Specialty & Generic names. XERS ranks #7 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	766,798	$55,102,104
2	PRGO	PERRIGO Co plc	3,318,826	$34,482,602
3	VTRS	Viatris Inc	1,282,665	$20,368,720
4	LNTH	Lantheus Holdings, Inc.	138,733	$15,391,039
5	ETON	Eton Pharmaceuticals, Inc.	297,232	$10,759,798
6	ANIP	Ani Pharmaceuticals Inc	92,691	$7,672,960
7	XERS	Xeris Biopharma Holdings, Inc. This page	64,320	$509,414

All Filings in XERS

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$509,414	64,320	-25.5%	Shares	Defined	2026-08-11
2026-03-31	$500,656	86,320	-14.4%	Shares	Defined	2026-05-11
2025-12-31	$791,939	100,884	0.0%	Shares	Defined	2026-02-10
2025-09-30	$821,195	100,884	-62.1%	Shares	Defined	2025-11-12
2025-06-30	$1,244,027	266,387	+54.2%	Shares	Defined	2025-08-06
2025-03-31	$948,584	172,784	+13.1%	Shares	Defined	2025-05-09
2024-12-31	$517,937	152,784	-11.6%	Shares	Defined	2025-02-10
2024-09-30	$492,434	172,784	0.0%	Shares	Defined	2024-11-12
2024-06-30	$388,764	172,784	-9.1%	Shares	Defined	2024-08-08
2024-03-31	$419,900	190,000	—	Shares	Defined	2024-05-09
No filing history on record for this holder in this stock.